Ferring Pharmaceuticals' EUFLEXXA(TM) to Serve as Sponsor for Sprint Force America Masters ...(s. J Bone Joint Surg Am. 2002; 84-A: 114...),Health
Navigation Links
Ferring Pharmaceuticals' EUFLEXXA(TM) to Serve as Sponsor for Sprint Force America Masters Track Club
Date:4/18/2008
s. J Bone Joint Surg Am. 2002; 84-A: 1142-1147.
'/>"/>
| SOURCE Ferring Pharmaceuticals Inc. Copyright©2008 PR Newswire. All rights reserved |
Related medicine news :
1. Ferring Announces $10,000 Grand Prize Winner of 2007 My Little Miracle Essay Contest
2. Access Pharmaceuticals Announces New Data on Angiolix(R)
3. Lotus Pharmaceuticals, Inc. Announces Fourth Quarter and Fiscal Year 2007 Results
4. Lotus Pharmaceuticals, Inc. Announces Conference Call to Discuss Fourth Quarter and Fiscal Year 2007 Results
5. Sunesis Pharmaceuticals Presents Nonclinical Data on SNS-595 at the Annual Meeting of the American Association for Cancer Research
6. Alexion Pharmaceuticals Invites You to Participate in its First Quarter 2008 Results Conference Call and Web Cast
7. Access Pharmaceuticals to Present New Data on ProLindac(TM) at the AACR Annual Meeting 2008 Conference
8. ISTA Pharmaceuticals Announces Receipt of Subpoena Relating to Promotional Practices for XIBROM(TM)
9. Aida Pharmaceuticals, Inc. Announces New Antibiotic Drug Under Development
10. Bayer HealthCare Pharmaceuticals, Amerinet Extend Contrast Media Agreement
11. Idenix Pharmaceuticals to Present at the Canaccord Adams Hepatitis C Conference
Post Your Comments:
(Date:11/24/2009)...nd New Markets build on their combined strength an... Baltimore, Md. (PRWEB) Novemb...com ), a private equity firm based in Baltimore, M...wmarketsvp.com ), a venture capital firm based in ...have acquired Ecoast Sales Solutions, Ltd. ("...
(Date:11/24/2009)...Removal Laser Clinic, located in San Diego, is hel..., with his new modeling career. The race to remove...ull time in the middle of 2010 is on. , ... Removal Laser Clinic, located in San Diego, is he...n, with his new modeling career. The race to remov...
(Date:11/23/2009)... of Michigan determined that only 663,000 of the a...C virus (HCV) infection received antiviral therapy... be declining, in part because only half of the pa... trend continues, by 2030 less than 15% of liver-r...ral therapy. This study, the first to analyze nat...
(Date:11/23/2009)...y STD Testing now provides super-private STD testi...uding Chlamydia, Herpes, HIV, Gonorrhea, Hepatitis... (PRWEB) November 23, 2009 --.../www.samedaystdtesting.com is a company that offe...ow available to accurately and anonymously test fo...
(Date:11/23/2009)...wire-FirstCall/--InfoLogix,Inc.(Nasdaq: IFLG ),ale...nsforthehealthcareandcommercialindustries,announce...cesatSiemensHealthServices,hasjoinedInfoLogixasVic...go: http://www.newscom.com/cgi-bin/prnh/20090618/N...hcareServicesforInfoLogix,Mr.Waywillberesponsiblef...
Breaking Medicine News(10 mins):Health News:Slate Capital Group and New Markets Venture Partners Acquire eCoast Sales Solutions 2Health News:Slate Capital Group and New Markets Venture Partners Acquire eCoast Sales Solutions 3Health News:Tattoo Removal on the Fastest U.S. Marine 2Health News:Alarming trend -- antiviral therapy to treat hepatitis C is declining in the US 2Health News:100% Anonymous, Confidential and Quick STD Screening Now Available with Same Day STD Testing 2Health News:Jim Way, Former Vice President at Siemens Health Services, Joins InfoLogix, Inc. as Vice President of Strategic Healthcare Services 2Health News:Jim Way, Former Vice President at Siemens Health Services, Joins InfoLogix, Inc. as Vice President of Strategic Healthcare Services 3[0] Slate Capital Group and New Markets Venture Partners Acquire eCoast Sales Solutions[0] Tattoo Removal on the Fastest U.S. Marine[0] Alarming trend -- antiviral therapy to treat hepatitis C is declining in the US[0] 100% Anonymous, Confidential and Quick STD Screening Now Available with Same Day STD Testing[0] Jim Way, Former Vice President at Siemens Health Services, Joins InfoLogix, Inc. as Vice President of Strategic Healthcare Services
...ontrol option maximizes UHPLC or HPLC productivity...available free of charge to all new and existing C...ay 11 Integrating a Corona ultra UHPLC detector...osciences, Inc., a Magellan Biosciences company an...
...NGTON, May 11 President Obama and U.S. Senate hea...nsumer protection laws as suggested by health insu...and the Bush Administration, said Consumer Watchdo...se Congress failed to enact Patients, Bill of Righ...
...HENGDU, China, May 11 /PRNewswire-Asia-FirstCall/ ... TPI ), a manufacturer and supplier of,modernized...ngdu, China, today,announced that management will ...4, 2009 after the market closes. , Interested ...
...VILLE, Colo., May 11 Bill Carlson, vice president... & Demand Chain Executive magazine,s 2009 Pro...mand-driven supply chain in healthcare. With more ...are the second-highest and fastest-growing expense...
...GTON, Va., May 11 HealthCentral ( www.HealthCe...dition-specific consumer health and wellness exper...reastCancer.org ( www.BreastCancer.org ), the nu...rship programs to be delivered on BreastCancer.org...
...men younger than 50 with prostate cancer, undergoi...eir chances for long-term survival, according to a...om the study done on the National SEER database sh...as radiotherapy or watchful waiting. , "When give...
Other Medicine News:Health News:ESA's Corona(R) Family of HPLC Detectors, Including the New Corona ultra(TM), Can Now be Controlled by Waters Empower(R) 2 Chromatography Software 2Health News:President Obama, Sens. Kennedy & Baucus: Don't Buy Insurer 'Compromise' for Bush-era Plan to Gut State Consumer Protection Laws 2Health News:President Obama, Sens. Kennedy & Baucus: Don't Buy Insurer 'Compromise' for Bush-era Plan to Gut State Consumer Protection Laws 3Health News:Tianyin Pharmaceutical Co., Inc. to Host Fiscal Year 2009 Third Quarter Earnings Conference Call on Friday, May 15, 2009 at 11:00 a.m. EDT 2Health News:GHX Vice President Bill Carlson Named to Supply & Demand Chain Executive's 2009 Pros to Know List 2Health News:HealthCentral.com Collaborates With BreastCancer.org, Providing Quality Awareness Sponsorships to #1 Breast Cancer Resource Online 2Health News:Surgery improves survival for prostate cancer patients younger than 50 2ESA's Corona(R) Family of HPLC Detectors, Including the New Corona ultra(TM), Can Now be Controlled by Waters Empower(R) 2 Chromatography SoftwarePresident Obama, Sens. Kennedy & Baucus: Don't Buy Insurer 'Compromise' for Bush-era Plan to Gut State Consumer Protection LawsTianyin Pharmaceutical Co., Inc. to Host Fiscal Year 2009 Third Quarter Earnings Conference Call on Friday, May 15, 2009 at 11:00 a.m. EDTGHX Vice President Bill Carlson Named to Supply & Demand Chain Executive's 2009 Pros to Know ListHealthCentral.com Collaborates With BreastCancer.org, Providing Quality Awareness Sponsorships to #1 Breast Cancer Resource OnlineSurgery improves survival for prostate cancer patients younger than 50
(Date:11/23/2009)...DAapprovalsoftwonewtherapiesforNon-Hodgkin,sLympho...ncludeofatumumab(Azerra(TM),GlaxoSmithKline)asathe...a(CLL)andromidepsin(Istodax(R),GloucesterPharmaceu...usT-celllymphoma(CTCL). ,, FORTWASHINGTON,Pa.,N...shavepromptedtheNationalComprehensiveCancerNetwork...
(Date:11/23/2009)...3/PRNewswire/--Reportlinker.comannouncesthatanewma... HolterMonitoringSystems-AGlobalMarketReview ,...onitoring-Systems---A-Global-Market-Review.html#ut...aign=prnewswire ,, Cardiovascularmonitoring...atientsneedtobecontinuouslymonitoredduringdiagnost...
(Date:11/23/2009)...ov.23/PRNewswire/--BridgePointMedicalannouncedtoda...foritscoronaryandperipheralChronicTotalOcclusion(C...ssingCatheterandtheStingray®CTORe-EntrySystem...etersthataredesignedtonavigatehighlydiseasedarteri...tyandstenting. ,, TheNationalHeart,LungandBlood...
Breaking Medicine Technology:NCCN Updates NHL Guidelines to Incorporate FDA Approvals of New Treatment Options 2NCCN Updates NHL Guidelines to Incorporate FDA Approvals of New Treatment Options 3Reportlinker Adds Holter Monitoring Systems - A Global Market Review 2Reportlinker Adds Holter Monitoring Systems - A Global Market Review 3Reportlinker Adds Holter Monitoring Systems - A Global Market Review 4Reportlinker Adds Holter Monitoring Systems - A Global Market Review 5BridgePoint Medical(R) Receives European CE Mark for Stingray(R) and CrossBoss(TM) for Opening Completely Blocked Arteries 2Micromet to Present at the 16th Annual NewsMakers in the Biotech Industry Conference on September 16 2009 14063 1Micromet to Present at the 16th Annual NewsMakers in the Biotech Industry Conference on September 16 2009 14063 2Micromet to Present at the 16th Annual NewsMakers in the Biotech Industry Conference on September 16 2009 14063 3Brains response to seeing food may be linked to weight loss maintenance 57213 1Brains response to seeing food may be linked to weight loss maintenance 57213 2University of Toronto study shows disparity of effect of climate change on UV radiation 9934 1University of Toronto study shows disparity of effect of climate change on UV radiation 9934 2...ion of Phase I/IIa Trial to 9 mg Dosage,Level, HOP...l/ --,Boston Life Sciences announced today that cl...rin(R), were presented in the Neurotrauma,and Crit...eting of,the American Association of Neurological ...entation, "Results of the Cethrin Phase I/IIa,Pros...
...ent Planned for Second Half of 2007 -, BRISBANE, A...,Progen Pharmaceuticals Limited today announced th...-88 in patients who had,previously undergone surgi...nstrated that 160 mg of PI-88 showed an improvemen...5 percent and,prolonged the time to tumour recurre...
Other Medicine Technology:Boston Life Sciences, Inc. Announces Presentation of Cethrin Phase,I/IIa 6-Month Results at 75th Annual Meeting of the American,Association of Neurological Surgeons 2Boston Life Sciences, Inc. Announces Presentation of Cethrin Phase,I/IIa 6-Month Results at 75th Annual Meeting of the American,Association of Neurological Surgeons 3Boston Life Sciences, Inc. Announces Presentation of Cethrin Phase,I/IIa 6-Month Results at 75th Annual Meeting of the American,Association of Neurological Surgeons 4Progen's Phase 2 Liver Cancer Trial Exceeds Efficacy Objective 2Progen's Phase 2 Liver Cancer Trial Exceeds Efficacy Objective 3| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |